EquityFlow › Companies › Medherant

Medherant

Healthtech · GB

Clinical-stage company with a transdermal drug-delivery patch (TEPI Patch).

Funding history

DateRoundAmount
Apr 2023Funding round
UK clinical-stage company Medherant raised £2.9M led by Mercia Asset Management for its testosterone patch.
$3.6M

Investors

Mercia Asset Management

Similar companies in Healthtech

OurMindTurnUpNanordica MedicalUncovr01HealthRem3dy HealthJoyvié HealthSembleTriomicsMuselyVITLEma Health
Explore funding flow on EquityFlow →